Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

Completed · Not applicable

Conditions studied: Dry Eye Syndrome

In brief

This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.

Key facts

Study ID

NCT01010282

Run by

Allergan

People needed

288

Starts

2009-11-01

Expected to finish

2010-04-01

Last updated by the study team

2015-08-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current use of an artificial tear at least twice daily, for at least three months prior to Day 1, on average
• Ability/agreement to wear habitual correction (glasses) during study period

You may not qualify if…

• Known allergy or sensitivity to the study product(s) or its components
• Anticipate contact lens wear during the study, or subject has worn contact lenses in the last six months
• Chronic use of systemic medications which may affect a dry eye condition
• Active ocular allergy or infection
• Use of Restasis® or other topical cyclosporine products within 3 months prior to Day 1
• Current use of any topical ophthalmic medications, have used within 2 weeks prior to Day 1, or are likely to use during study.

Where it is running

• Study site — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.